NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 20.05
(0.25%)
TWD 20.05
(0.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 13.85 Million TWD | -62.85% |
| 2022 | 37.28 Million TWD | -2.56% |
| 2021 | 38.26 Million TWD | -45.31% |
| 2020 | 69.97 Million TWD | 57.46% |
| 2019 | 54.68 Million TWD | 421.21% |
| 2018 | -8.01 Million TWD | 75.11% |
| 2017 | -55.59 Million TWD | 12.6% |
| 2016 | -63.6 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 4.29 Million TWD | -12.41% |
| 2024 Q2 | 4.29 Million TWD | 0.0% |
| 2023 Q2 | 6.04 Million TWD | 199.68% |
| 2023 FY | - TWD | -62.85% |
| 2023 Q3 | 4.9 Million TWD | -18.77% |
| 2023 Q1 | 2.01 Million TWD | -87.28% |
| 2023 Q4 | 7.8 Million TWD | 59.05% |
| 2022 Q2 | 21.42 Million TWD | 0.0% |
| 2022 Q4 | 15.85 Million TWD | 0.0% |
| 2022 FY | - TWD | -2.56% |
| 2021 Q2 | -9.78 Million TWD | 0.0% |
| 2021 Q4 | 48.05 Million TWD | 0.0% |
| 2021 FY | - TWD | -45.31% |
| 2020 FY | - TWD | 57.46% |
| 2020 Q4 | 14.28 Million TWD | 0.0% |
| 2020 Q2 | 55.68 Million TWD | 0.0% |
| 2019 Q4 | 28.18 Million TWD | 0.0% |
| 2019 FY | - TWD | 421.21% |
| 2018 FY | - TWD | 75.11% |
| 2017 FY | - TWD | 12.6% |
| 2016 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 96.481% |
| Level Biotechnology Inc. | 98.7 Million TWD | 85.968% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 154.888% |
| GlycoNex Incorporation | -126.82 Million TWD | 110.92% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 109.638% |
| OBI Pharma, Inc. | -855.08 Million TWD | 101.62% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 36.497% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 113.367% |
| Visgeneer Inc. | 973 Thousand TWD | -1323.433% |
| Neith Corporation | -33.61 Million TWD | 141.208% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 106.11% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 101.397% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 897.352% |
| Enimmune corporation | -228.96 Million TWD | 106.049% |
| TaiRx, Inc. | -208.64 Million TWD | 106.638% |
| CHO Pharma, Inc. | -277.73 Million TWD | 104.987% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 81.259% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 79.969% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 97.887% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 60.245% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 152.662% |
| RBC Bioscience Corporation | 36.54 Million TWD | 62.104% |
| NaviFUS Corp. | -55.79 Million TWD | 124.823% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 102.029% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 141.962% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 125.221% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 130.957% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 122.217% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 117.297% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 112.245% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 86.127% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 122.52% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 101.293% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 129.95% |
| AP Biosciences Inc | -325.51 Million TWD | 104.255% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 98.521% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 96.805% |
| EirGenix Inc. | -664.4 Million TWD | 102.085% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 52.455% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 104.08% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 178.134% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 130.811% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 119.205% |
| VBI | -6.97 Million TWD | 298.652% |
| BiOptic Inc. | 65.03 Million TWD | 78.705% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 183.444% |
| Sinew Pharma Inc. | -163.63 Million TWD | 108.464% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 92.802% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 101.326% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 138.638% |
| Intech Biopharm Corporation | -219.58 Million TWD | 106.307% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 102.054% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 108.61% |
| TCI GENE Inc. | 25.98 Million TWD | 46.692% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 112.518% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 104.88% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 109.488% |
| PharmaEngine, Inc. | 347.3 Million TWD | 96.012% |
| Savior Lifetec Corporation | 219.6 Million TWD | 93.693% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 91.958% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 114.963% |
| Acepodia, Inc. | -764.51 Million TWD | 101.812% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 103.01% |